¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"permissible internal dose"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • internal carotid artery
    ¼Ó¸ñµ¿¸Æ, ³»°æµ¿¸Æ
  • internal carotid nerve
    ¼Ó¸ñµ¿¸Æ½Å°æ, ³»°æµ¿¸Æ½Å°æ
  • internal carotid plexus
    ¼Ó¸ñµ¿¸Æ½Å°æ¾ó±â, ³»°æµ¿¸Æ½Å°æÃÑ
  • internal cerebral veins
    ¼Ó´ë³úÁ¤¸Æ, ³»´ë³úÁ¤¸Æ
  • internal compensation
    ºÐÀÚ³»º¸»ó
  • internal conjugate diameter
    ¼Ó¾ÕµÚÁö¸§, ³»°áÇÕ°æ
  • internal conversion
    ³»ºÎº¯È¯
  • internal decompression
    ³»°¨¾Ð(¼ú)
  • internal dosimetry
    ü³»¼±·®ÃøÁ¤(¹ý)
  • internal ear
    ¼Ó±Í, ³»ÀÌ
  • internal fecundation
    ü³»¼öÁ¤, ¸ö¾È¼öÁ¤
  • internal fistula
    ¼Ó»û±æ, ³»´©°ø
  • internal fixation
    ³»(ºÎ)°íÁ¤
  • internal genu
    ¿Ü¹Ý½½, ¹Û±ÁÀ̹«¸­
  • internal hemorrhoid
    ³»Ä¡ÇÙ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • therapeutic dose
    Ä¡·á¿ë·®, Ä¡·á¼±·®
  • high-dose
    °í¿ë·®
  • dose-response relationship
    ¿ë·®¹ÝÀÀ°ü°è
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • internal compensation
    ºÐÀÚ³»º¸»ó
  • internal conversion
    ³»ºÎº¯È¯
  • internal acoustic canal
    ¼Ó±Ó±æ, ³»À̵µ
  • internal decompression
    ³»°¨¾Ð¼ú
  • internal dosimetry
    ü³»¼±·®ÃøÁ¤
  • internal conjugate diameter
    ¾ÈÂʾյÚÁö¸§, ³»°áÇÕ°æ
  • internal ear
    ¼Ó±Í, ³»ÀÌ
  • internal environment
    ³»ºÎȯ°æ
  • internal fecundation
    ü³»¼öÁ¤, ¸ö¾È¼öÁ¤
  • internal fistula
    ¼Ó»û±æ, ³»·ç
  • internal genu
    (¢¡genu valgum) ¿Ü¹Ý½½, ¾È±ÁÀ̹«¸­
  • internal hemorrhoid
    ¼ÓÄ¡Áú
  • internal hordeolum
    ¼Ó´Ù·¡³¢, ³»¸Æ¸³Á¾
  • internal irradiation hazard
    ü³»ÇÇÆøÀ§Çè
  • internal
    ¼Ó-, ³»-
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • genu of internal capsule
    ¼Ó¼¶À¯¸·¹«¸­
  • inner ear =internal e.
    ³»ÀÌ
  • inner ear =internal e.
    ³»ÀÌ(Ò®ì¼).
  • inner language =internal speech
    ³»¾ð¾î
  • posterior internal vertebral venous plexus
    µÚ¼ÓôÁÖÁ¤¸Æ¾ó±â
  • posterior limb of internal capsule
    ¼Ó¼¶À¯¸·µÚ´Ù¸®
  • ED 50=£¾effective dose 50%
    50% À¯È¿·®, Áß°£À¯È¿·®.
  • ED 50=£¾effective dose 50%
    50% À¯È¿·®.
  • ED 50=ÊÝeffective dose 50%
    50% À¯È¿·®.
  • ED=ÊÝeffective dose
    À¯È¿·®.
  • ID50 (50% infectious dose)
    50% °¨¿°·®
  • LD = lethal dose
    Ä¡»ç·®.
  • LD50 (50% lethal dose)
    50% Ä¡»ç·®
  • LD= lethal dose
    Ä¡»ç·®.
  • MED => minimum effective dose
    ÃÖ¼ÒÈ«¹Ý·®
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • anterior internal vertebral venous plexus
    ¾Õ¼ÓôÁÖÁ¤¸Æ¾ó±â
  • anterior limb of internal capsule
    ¼Ó¼¶À¯¸·¾Õ´Ù¸®
  • apparatus internal compliance
    ±â°è³»Åº¼º.
  • artery, internal maxillary
    ³»»ó¾Çµ¿¸Æ
  • band of internal granular layer
    ¼Ó°ú¸³Ãþ¼¶À¯ÁÙ
  • band of internal pyramidal layer
    ¼ÓÇǶó¹ÔÃþ¼¶À¯ÁÙ
  • branches of internal capsule
    ¼Ó¼¶À¯¸·°¡Áö
  • bronchial branches of internal thoracic artery
    ³»Èä°ûµ¿¸ÆÀÇ ±â°üÁö(µ¿¸Æ)Áö.
  • canal, internal acoustic
    ³»À̵µ
  • canal, internal auditory
    ³»À̵µ
  • ear, inner =internal e.
    ³»ÀÌ
  • ear, internal
    ³»ÀÌ
  • fundus of internal acoustic meatus
    ¼Ó±Í±æ¹Ù´Ú
  • genu of internal capsule
    ¼Ó¼¶À¯¸·¹«¸­
  • inner ear =internal e.
    ³»ÀÌ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Internal ear
    ¼Ó±Í [³»ÀÌ]
    [¿¾ ¿ë¾î] ³»ÀÌ
  • Internal acoustic meatus
    ¼Ó±Í±æ [³»À̵µ]
    [¿¾ ¿ë¾î] ³»À̵µ
  • Fundus of internal acoustic meatus
    ¼Ó±Í±æ¹Ù´Ú
    [¿¾ ¿ë¾î] ³»À̵µÀú
  • Vessels of internal ear
    ¼Ó±ÍÇ÷°ü
    [¿¾ ¿ë¾î] ³»ÀÌÇ÷°ü
  • Internal acoustic pore
    ¼Ó±Ó±¸¸Û
    [¿¾ ¿ë¾î] ³»À̰ø
  • Internal lip
    ¼Ó´É¼±
    [¿¾ ¿ë¾î] ³»¼ø
  • Internal cerebral veins
    ¼Ó´ë³úÁ¤¸Æ
    [¿¾ ¿ë¾î] ´ë³ú³»Á¤¸Æ
  • Internal occipital protuberance
    ¼ÓµÚÅë¼ö»ÀÀ¶±â
    [¿¾ ¿ë¾î] ³»ÈĵÎÀ¶±â
  • Internal coat
    ¼Ó¸·
    [¿¾ ¿ë¾î] ³»¸·
  • Internal surface
    ¼Ó¸é
    [¿¾ ¿ë¾î] ³»¸é
  • Internal carotid artery
    ¼Ó¸ñµ¿¸Æ
    [¿¾ ¿ë¾î] ³»°æµ¿¸Æ
  • Internal carotid nerve
    ¼Ó¸ñ½Å°æ
    [¿¾ ¿ë¾î] ³»°æµ¿¸Æ½Å°æ
  • Internal carotid plexus
    ¼Ó¸ñ½Å°æ¾ó±â
    [¿¾ ¿ë¾î] ³»°æµ¿¸Æ½Å°æÃÑ
  • Internal jugular vein
    ¼Ó¸ñÁ¤¸Æ
    [¿¾ ¿ë¾î] ³»°æÁ¤¸Æ
  • Internal carotid venous plexus
    ¼Ó¸ñÁ¤¸Æ¾ó±â
    [¿¾ ¿ë¾î] °æµ¿¸Æ°üÁ¤¸ÆÃÑ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • internal respiration
    ³»È£Èí(Ò®û¼ýå)
  • internal standard
    ³»Ç¥ÁØ(Ò®øöñÞ)
  • internal standardization
    ³»Ç¥ÁØÈ­(Ò®øöñÞûù)
  • internal volume
    ³»ºÎ¿ëÀû(Үݻé»îÝ)
  • absorbed dose
    Èí¼ö·® (ýåâ¥Õá)
  • air dose
    ´ë±â¼±·®(ÓÞѨàÊÕá)
  • booster dose
    ºÎ½ºÅÍ ·®(Õá)
  • dose-response curve
    ¿ë·®´ëÀÀ °î¼±(é»ÕáÓßëëÍØàÊ)
  • exposure dose
    ³ëÃâ·®(ÖÚõóÕá)
  • fractionated dose
    ºÐÇÒ·®(ÝÂùÜÕá)
  • half-value dose
    ¹Ý(Úâ)°ª ¼±·®(àÊÕá)
  • lethal dose
    Ä¡»ç·®(öÈÞÝÕá)
  • median effective dose
    Á¤Áß À¯È¿·®(ïáñéêóüùÕá)
  • median hemolytic dose
    Á¤Áß ¿ëÇü·®(ïáñééÁúìÕá)
  • median immunizing dose
    Á¤Áß ¸é¿ª·®(ïáñéØóæµÕá)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • midbreast dose
    À¯¹æÁß¾ÓÁ¶»ç¼±·®
  • minimal effective dose
    ÃÖ¼ÒÀ¯È¿·®
  • radiation absorbed dose
    ¶óµå, ¹æ»ç¼±Èí¼ö¼±·®
  • relative dose
    ºñ±³Á¶»ç·®, »ó´ëÁ¶»ç·®
  • single dose
    ÀÏȸ·®
  • skin dose
    ÇǺμ±·®
  • internal
    ³»ÀÇ, ³»ºÎÀÇ
  • internal acoustic canal
    ³»À̵µ
  • internal anal sphincter
    ³»Ç×¹®°ý¾à±Ù
  • internal capsule
    ³»Æ÷
  • internal carotid artery
    ³»°æµ¿¸Æ
  • internal ear
    ³»ÀÌ
  • internal echo
    ³»ºÎ¿¡ÄÚ
  • internal fistula
    ³»·ç
  • internal focus
    ³»ºÎÃÊÁ¡
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
MDPD maximum daily permissible dose
IAD inactivating dose; instructional advance directive; internal absorbed dose
CD cadaver donor; canine distemper; canine dose; carbohydrate dehydratase; carbon dioxide; cardiac dise...
LD labor and delivery; laboratory data; labyrinthine defect; lactate dehydrogenase; laser Doppler; lear...
MD Doctor of Medicine [Lat. Medicinae Doctor]; magnesium deficiency; main duct; maintenance dose; major...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
ABIM American Board of Internal Medicine
CI Confidence Internal
CIDR Controlled Internal Drug Release
GIM General internal medicine
I Internal
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • internal derangement of TMJ
    ¾Ç°üÀý ³»ÀåÁõ
  • internal echo
    ³»ºÎ ¿¡ÄÚ
  • internal environment
    ³»ºÎ ȯ°æ
  • internal fixation
    ³»ºÎ °íÁ¤
  • internal focusing
    ³»ºÎ ÃÊÁ¡ Á¶Àý
  • internal granuloma
    ¾Ç°ñ³» À°¾ÆÁ¾
  • internal hemorrhoid
    ³»Ä¡ÇÙ
  • internal iliac artery
    ³»Àå°ñ µ¿¸Æ
  • internal irradiation
    ü³» Á¶»ç, ³»ºÎ Á¶»ç
  • internal jugular vein
    ³»°æÁ¤¸Æ
  • internal mammary artery
    ³»À¯¹æ µ¿¸Æ
  • internal medicine
    ³»°ú, ³»°úÇÐ
    ÀϹÝÀûÀ¸·Î ³»Àå¿¡ ¿øÀÎÀÌ ÀÖ´Â ÁúȯÀ» ´Ù·ç´Â ÀÓ»ó ÀÇÇÐ. ¾ö¹ÐÇÑ Á¤ÀǸ¦ ³»¸®±â´Â ¾î·ÆÁö¸¸ 15¼¼ ÀÌ»ó »ç¶÷ÀÇ °¢Á¾ Áúº´À» Áø´ÜÇÏ¸ç ¼ö¼úÀû ¿ä¹ýÀ» »ç¿ëÇÏÁö ¾Ê°í ¾à¹° Ä¡·á¸¦ ÇÏ´Â ºÎ¹®À» ¸»ÇÑ´Ù. ³»°ú¿¡¼­ ´Ù·ç´Â Áúº´À» ºÐ·ùÇÏ¸é °¨¿°Áõ, ¼øÈ¯±â Áúȯ, ½Å°æ°è Áúȯ, ¼ÒÈ­±â°è Áúȯ, Ç÷¾× Áúȯ, È£Èí±â Áúȯ, ³»ºÐºñ¼± Áúȯ, ºñ´¢±â Áúȯ, ¾Ë·¹¸£±â¼º Áúȯ, ½ÅÁø´ë»ç Áúȯ, ±³¿øº´, Áßµ¶ µî ¸Å¿ì ¹üÀ§°¡ ³Ð´Ù. ¿ª»çÀûÀ¸·Î º¸¸é ³»°úÇÐÀÌ Çй®À¸·Î¼­ ¹ßÀüÇÑ °ÍÀº »ý¸®ÇÐ, ÇØºÎÇÐÀÌ ¹ß´ÞÇÑ 16~17¼¼±âÀÇ ÀÏÀÌ´Ù. 18¼¼±â¿¡ ü¿Â°è¸¦ ÀÌ¿ëÇÏ´Â ¹æ¹ýÀÌ ¹ß´ÞÇϰí ŸÁø¹ýÀÌ ¹ß¸íµÇ¾úÀ¸¸ç, 19¼¼±â¿¡´Â ûÁø±â°¡ ¹ß¸íµÊ¿¡ µû¶ó ´õ¿í Áøº¸ÇÏ¿´´Ù. 19¼¼±â ÈĹÝÀÇ X¼± ¹ß°ß°ú µ¶ÀÏÀÇ R. ÄÚÈå¿Í ÇÁ¶û½ºÀÇ L. ÆÄ½ºÅ𸣠µî¿¡ ÀÇÇÑ ¼¼±ÕÇÐÀÌ È®¸³µÊÀ¸·Î½á ³»°úÇÐÀº ºñ¾àÀûÀ¸·Î ¹ßÀüÇÏ¿´´Ù. ±Ù³â¿¡´Â Áúȯº°, Àå±âº°·Î Àü¹® ºÐ¾ß°¡ µ¶¸³, ºÐ°úÇÏ´Â °æÇâÀÌ ÀÖ´Ù. ¿¹¸¦ µé¸é, ¼øÈ¯±â°ú, ¼ÒÈ­±â°ú, Ç÷¾×°ú µîÀÌ´Ù.
  • internal oblique ridge
    ³»»ç¼±
  • internal obturator muscle
    ³»Æó¼â±Ù
  • internal occipital protuberance
    ³»ÈĵΠÀ¶±â
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
minimal infecting dose <microbiology> The smallest quantity of infectious material regularly producing infection; usually expressed as I.D.50, the quantity causing infection in 50% of a suitable series of animals or cells (cell cultures).
(05 Mar 2000)
minimal lethal dose <pharmacology> The minimal dose of a toxic substance or infectious agent that is lethal, as assayed in various experimental animals (e.g., the least amount of diphtheria toxin that, on an average, kills a 250-g guinea pig within 96 hours after subcutaneous inoculation).
When followed by a subscript (generally "MLD50"), denotes the minimal dose that is lethal to a certain percentage (e.g., 50%) of animals so assayed, LD05.
See: lethal dose.
(05 Mar 2000)
minimal reacting dose The minimal dose of a toxic substance causing a reaction, as manifested in the skin of a series of susceptible test animals; the assay is based on the development of a characteristic, minimal but definite, "standard," focal inflammation (congestion and oedema, induration, degenerative changes, and desquamation of epidermal cells).
(05 Mar 2000)
cumulative dose The total dose resulting from repeated exposures to radiation of the same part of the body or of the whole body.
(05 Mar 2000)
curative dose The quantity of any substance required to effect the cure of a disease or that will correct the manifestations of a deficiency of a particular factor in the diet, effective dose used with therapeutically applied compounds.
Synonym: therapeutic dose.
(05 Mar 2000)
preventive dose The smallest amount of any substance that will prevent occurrence of symptoms of a disease or the consequences of a lack of a particular factor in the diet.
(05 Mar 2000)
high dose tolerance The induction of tolerance by exposure to high doses of antigen.
(05 Mar 2000)
sensitizing dose In experimental anaphylaxis, the antigenic inoculum that renders an animal susceptible (sensitive) to anaphylactic shock following a subsequent inoculum (shocking dose) of the same antigen (anaphylactogen).
(05 Mar 2000)
shocking dose In experimental anaphylaxis, the inoculum of antigen that causes anaphylactic shock in an animal sensitised by a previous inoculum (sensitizing dose) of the same antigen.
(05 Mar 2000)
skin dose The quantity of radiation delivered to the skin surface.
(05 Mar 2000)
daily dose The total amount of a remedy that is to be taken within 24 hours.
(05 Mar 2000)
depth dose The dose of radiation at a distance beneath the surface, including secondary radiation or scatter, in proportion to the dose at the surface.
(05 Mar 2000)
divided dose A definite fraction of a full dose; given repeatedly at short intervals so that the full dose is taken within a specified period, usually one day.
Synonym: fractional dose.
(05 Mar 2000)
dose 1. <pharmacology> A quantity to be administered at one time, such as a specified amount of medication.
2. <radiobiology> A general term denoting the quantity of radiation or energy absorbed. For special purposes it must be appropriately qualified. If unqualified, it refers to absorbed dose. Unit of absorbed dose is the rad. The SI unit is the gray (1 Gy = 1 J kg-1 = 100 R).
Origin: Gr. Dosis = a giving
(16 Dec 1997)
dose-effect curve This is a graph drawn to show the relationship between the dose of a drug or other chemical and the magnitude of the graded effect that it produces.
(09 Oct 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • internal storage
    (Àü»ê)³»ºÎ±â¾ïÀåÄ¡
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á